ArticleMolecules (Basel, Switzerland)2019

ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation.

Luis J Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.